Randomized phase II study of gemcitabine and S-1 combination versus gemcitabine alone in the treatment of unresectable advanced pancreatic cancer (Japan Clinical Cancer Research Organization PC-01 study)
Masato Ozaka, Yuji Matsumura, Hiroshi Ishii, Yasushi Omuro, Takao Itoi, Hisatsugu Mouri, Keiji Hanada, Yasutoshi Kimura, Iruru Maetani, Yoshinobu Okabe, Masaji Tani, Takaaki Ikeda, Susumu Hijioka, RyoVolume:
69
Language:
english
Pages:
8
DOI:
10.1007/s00280-012-1822-1
Date:
May, 2012
File:
PDF, 406 KB
english, 2012